BioNTech SE (BNTX)
NASDAQ • Healthcare
May 20, 2026 at 16:00 UTC
About BioNTech SE
BioNTech SE is a biotechnology company that turns insights in immunology into therapies designed for serious diseases. The model links research platforms with clinical programs and manufacturing methods that can be scaled when evidence supports them. Work spans mRNA and other modalities, but the operating tone stays consistent: design carefully, test with rigor, and communicate results so physicians and regulators can act with confidence. Partnerships extend reach without changing that core rhythm. The goal is to move promising ideas into treatments that fit the routines of modern medicine, with supply and guidance that are as clear as the science behind them.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BioNTech SE's Technical Indicators Summary
BNTX carries a bearish technical profile highlighted by weakening momentum and negative volume dynamics. RSI sits in the mid-30s and MACD is clearly negative, while price is below the short-, medium- and long-term moving averages including the 200-day EMA, which signals broad-based resistance. Volatility is moderate and ATR shows meaningful price movement, and on-balance volume is negative, indicating distribution. The VWAP is slightly above the market, reinforcing intraday selling pressure. Technical takeaway: downside-favoring conditions with momentum and volume confirming seller dominance.
| Indicator | Value |
|---|---|
RSI (14) | 35.79 |
Stochastic %K (14, 3, 3) | 5.89 |
CCI (20) | -101.82 |
WPR (14) | -89.98 |
Momentum (10) | -6.46 |
MFI | 24.06 |
MACD Level (12, 26) | -2.58 |
Bollinger Bands | $84.61 - $107.51 |
ATR (14) | $3.27 (3.69%) |
ADX (14) | 20.26 |
OBV | -19,945,346 |
VWAP | $88.87 |
Classic Pivot Point | $88.15 |
Fibonacci Pivot Point | $88.15 |
Exponential Moving Averages | $91.43 - $100.74(5 indicators) |
Simple Moving Averages | $91.34 - $96.06(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Into the close, BNTX still reflected its 2.93% upside gap from yesterday, finishing near 90.36. By the final tick, BNTX options remained one-sided, with a deeply bullish put/call ratio of 0.47. BNTX edged higher on news of a supervisory-board expansion adding oncology and commercialization expertise, fueling bullish option skew.
Price Change
from $90.49 close
-$0.15
Trading Volume
Below avg (868.5K)
828.7K
vs S&P 500 Today
Outperforming Market
+1.52%
52-Week Position
Lower range
24.4%
Updated: May 20, 2026 at 20:04 UTC
Quote Summary
BNTX Headlines
DACH-Focused Stock Moves Across Key Sectors
March 21, 2026
Markets Swoon as Bitcoin, Tech and Crypto Firms Slide
February 5, 2026